Researchers at the Institute of Bioengineering and Nanotechnology (IBN) could have a new arsenal for the treatment of meningitis and infections caused by bacteria and fungi resistant to drugs through a new peptide nanoparticles. The major brain infections such as meningitis, encephalitis, cause death, hearing loss and brain injury patients.

The membrane of the brain is impenetrable by the more conventional antibiotics because of their structure too much. The oligopeptide of nanoparticles IBN contains an element enabling it to pass through the blood brain barrier to reach the infected areas. This treatment damages the structure of the element in the pathogenic brittle. These nanoparticles are readily in bacteria, yeast or fungus to destabilize and destroy them. In addition, nanoparticles are more effective than traditional drugs to inhibit the growth of fungal infections. Preclinical trials have shown the biocompatibility and absence of lesions on the liver and kidneys. IBN therefore the analysis in this direction in order to treat these patients with brain infections peptide nanoparticles.